Published 15th April 2024
Ahead of the 31st of January 2024 marking a year until all EU clinical trials need to be compliant with the EU Clinical Trials Regulation (CTR), this whitepaper delves into different aspects we have observed that can become ‘sticking points’ for Sponsors wanting to conduct clinical trials under the CTR. Our analysis has highlighted six key topics, encompassing our experience of the overall clinical trial application (CTA) assessment process, data transparency and publication, transitioning from the Clinical Trial Directive (CTD) to the CTR, the EU CTR Systems Environment, EU Legal Representative requirements, and Article 32 paediatric requirements.
Need personalised assistance to prepare for the new regulation? Contact our experts at hello@dlrcgroup.com
Download nowPublished Jul 25, 2024
Published Jul 24, 2024
Published Jul 23, 2024
Published Jul 19, 2024
Published Jul 18, 2024
Published Jul 01, 2024
Published Jul 01, 2024
Published Jun 27, 2024
Published Jun 26, 2024